HCP Live

May 05, 2025

Facilitating an Early Diagnosis in ATTR-CM

Panelists discuss how early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) relies on clinical awareness, recognizing red flag symptoms, and utilizing…

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion